Self-renewal and
pluripotency
Their ability to self-renew
indefinitely and to differentiate into cells of all three germ layer types
(a differentiative capacity termed 'pluripotency'), makes embryonic stem
(ES) cells one of the most promising subjects of study in regenerative
medicine, as well as an attractive model system for research into a spectrum
of developmental processes. However, the mechanisms by which ES cells
are able to maintain these capabilities are incompletely understood, and
a better understanding of the stemness of these cells will be necessary
in order to be able to take best advantage of their remarkable properties.
Two of the biggest
challenges that now face stem cell research are the determination of the
factors that allow ES cells to generate limitlessly self-renewable progeny,
and the identification of molecules that direct the dividing ES cell to
produce daughter cells of specific types. Hitoshi Niwa's research addresses
both of these challenges, with the aims of developing solid scientific
foundations and reliable technologies to support this exciting field of
biomedicine.
Inducing differentiation
The development of
methods by which undifferentiated ES cells can be prompted to commit to
a specific cell lineage is a field of central importance to the stem cell
research community. Studying factors identified in work on knockout mice,
the Niwa research team has been engaged in the analysis of transcription
factors with potential roles in the development of extraembryonic cell
lineages, extraembryonic endoderm and trophectoderm. Extraembryonic
endoderm derivatives include the parietal and visceral endoderm, which
give rise to the yolk sac covering embryos in utero during development,
and trophectoderm derivatives, the source of the placenta that sustains
the developing mammalian embryos.
In
previous research, the Niwa lab showed that the overexpression of GATA
transcription factors such as Gata-4 or Gata-6 resulted in the specific
conversion of undifferentiated ES cells into extraembryonic endodermal
cells, and that the exogenous expression of either of these factors simultaneously
induced the expression of the other from the endogenous gene. New work
suggests that the homeobox gene Cdx-2
can serve as a similar trigger for the induction of trophectoderm from
ES cells expressing low levels of the pluripotency maintaining gene, Oct
3/4. Using regulable activation of Cdx-2
in vitro, Niwa successfully induced ES cells to differentiate into trophoblast
stem cells. These results, in combination with the GATA study, have led
to the development of a model in which Oct 3/4, when maintained at an
appropriate mid-range level, inhibits the differentiation of ES cells
into either the trophectodermal or primitive endodermal lineages by suppressing
Cdx-2 and Gata-6, respectively.
Maintaining pluripotency
The POU-family transcriptional
regulator Oct 3/4 was the first factor found to elicit multiple differentiative
outcomes dependent on its expression level. ES cells expressing median
levels of Oct 3/4 maintain their pluripotency, while its overexpression
results in differentiation into primitive endoderm and mesoderm and its
inhibition causes the cells to take up a trophectodermal fate. These findings
established Oct 3/4 as a primary regulator of pluripotency in ES cells,
but the function of this regulator in the commitment of more specific
lineages remains an open issue.
In 2003, the Niwa
lab contributed to a study that demonstrated a role for Oct 3/4 in neurogenesis
promoted by stromal cell derived inducing activity. The researchers found
that SDIA acts to maintain Oct 3/4 expression in ES cells, which appears
to be important as a promoter of the differentiation of ES cells into
neural lineages. ES cells from which Oct 3/4 had been deleted lost their
ability to differentiate into neurons, while heightened levels of Oct
3/4 intensified the neurogenic effects of SDIA. This finding raises the
possibility that, in addition to its function as a maintainer of pluripotency,
Oct 3/4 also plays a second key role by regulating neuronal differentiation
in a concentration-dependent manner.
ES cell growth
in culture
This goal of controlling
culture conditions to achieve specific outcomes is important to the growth
of ES cells in vitro as well. The Niwa lab is working to develop a serum-
and feeder-cellfree system for culturing mouse ES cells, which necessitates
developing a detailed picture of both the extrinsic factors and the intrinsic
networks that function in these cells in culture. It is known that a single
ES cell in isolation will fail to proliferate, while colonies of such
cells grow normally. It is also known that even isolated single cells
can be induced to proliferate if the culture medium from a larger ES cell
colony is transferred to the single cell's plate, suggesting that ES cells
produce a growth-stimulating factor that acts by community effect. Niwa
has developed an assay system to isolate candidate molecules for this
putative 'stem cell autocrine factor' (SAF), and is actively pursuing
the characterization of the most promising candidates. The results of
these analyses should improve the ability of researchers to grow ES cells
in culture, facilitating the study of these fascinating and potentially
revolutionarily important cells. |
Team Leader
Hitoshi Niwa
Research Scientist
Shinji
Masui
Kazuya Ogawa
Satoshi Ohtsuka
Yayoi Toyooka
Visiting Scientist
Itsuro Sugimura
Hiroyuki Kitajima
Technical Staff
Rika Yagi
Kadue
Takahashi
Student Trainee
Ken-ichi Tominaga
Yoko Sekita
Yuko Iwamatsu
Sayako Matsui
Daisuke Shimosato
Assistant
Rie Kuroki |
|